Novo plots Victoza launches in Germany, U.K.

Armed with European approval for its new diabetes treatment Victoza, Novo Nordisk plans a launch this summer in Britain, Germany and Denmark, with other European markets to follow. The company is still awaiting FDA's blessing after thyroid safety questions prompted questions from an expert advisory panel. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.